Healthcare Costs

As new MASH therapeutics hit the market, a strategic partnership between Echosens and Gastro Health signals a lucrative shift from liver biopsies to non-invasive, data-driven diagnostics.

By integrating cash prices directly into the EHR workflow, Epic's upcoming Prescription Marketplace challenges traditional PBMs and empowers patients.

As healthcare costs rise, insurers are pivoting from reactive claims to proactive community wellness, building social resilience through public sports festivals.

CMS approval for B. Braun's Stimuplex needles under the NOPAIN Act signals a major shift in how outpatient centers fund opioid-sparing pain management.

As a new foundation offers free seminars for Thyroid Eye Disease, it highlights the complex intersection of rare disease advocacy and pharmaceutical marketing.

As Medicare ramps up scrutiny on skin substitutes, a new zero-upfront-cost biologic program promises clinical results and protection from financial ruin.

As ComPsych opens its 2026 Health at Work Awards, companies are grappling with the rising costs of GLP-1s and a demand for equitable mental health support.

As 11,000 Americans turn 65 daily, the world's largest home care provider is using HGTV star power to normalize costly lifestyle and care transitions.

Phathom Pharmaceuticals is using predictive modeling to prove its premium-priced drug VOQUEZNA can beat generic PPIs by preventing long-term complications.

Driven by fiduciary lawsuits, GLP-1 costs, and hollow transparency claims, employers are abandoning pharmacy advisors at a record pace.

As Medicare's Annual Enrollment Period begins, new data reveals that administrative complexity and rising costs are pushing seniors to skip essential medical care.

Trupanion has tapped Simon Cowell to crack the 95% of North American pets without insurance. But can celebrity trust mask the reality of rising premiums?

Medela's new Drainology hub aims to standardize post-op chest drainage, highlighting the growing economic influence of medtech in clinical education.

As healthcare costs soar, Midwest labor unions are partnering with direct care providers to bypass traditional insurers and cut out-of-pocket expenses.

As generative AI supercharges Medicare scams, a new ambient education program aims to fortify the 'human behavior layer' against hyper-realistic deepfakes.

As the healthcare industry shifts from centralized treatment to decentralized prevention, Blue Zones taps former health system executive Brett McClung as CEO.

PEI's $32M drug subsidy renewal isn't just about local healthcare—it's a critical financial prototype for Canada's looming national pharmacare rollout.

A new Real-Price Index reveals the hidden fees, dose escalators, and teaser rates in the booming GLP-1 telehealth market, sparking a transparency revolution.

As Eve Wellness opens its second Bay Area clinic, the direct-to-consumer model sparks debate over AI ultrasound, patient autonomy, and false positives.

New clinical data reveals how dynamic perfusion technology is preventing catastrophic bedsores in critically ill ECMO patients and saving hospitals millions.